Epigenomics and Disease
The Section of Epigenomics and Disease is currently comprised of the Beta Cell Genome Regulation Laboratory and the NIHR Imperial BRC Genomics Facility. Led by Professor Jorge Ferrer, the Section’s primary focus is the genome regulation of pancreatic beta cells and its implications for human diabetes.
The Beta Cell Genome Regulation Laboratory works to understand disease mechanisms and to develop novel therapies for diabetes; this goal is supported by the NIHR Imperial BRC Genomics Facility, whose mission is to support the use of genome technologies and information to translate new genomic discoveries into medical advances.
Research groups and section leadership
Head of Epigenomics and Disease
Professor Jorge Ferrer is interested in understanding genome regulation of pancreatic beta cells and its implications for human diabetes.